Liontown Limited stock jumps 4.6% as lithium demand outlook firms; Jan 29 report next
7 January 2026
1 min read

Liontown Limited stock jumps 4.6% as lithium demand outlook firms; Jan 29 report next

Sydney, January 7, 2026, 17:58 AEDT — Market closed

  • Liontown ended up 4.6% at A$2.03 after trading as high as A$2.04
  • A battery storage-led lift in lithium demand is pulling investors back into the sector
  • Next catalyst is Liontown’s December-quarter report due Jan. 29

Liontown Limited (ASX:LTR) shares closed up 4.6% at A$2.03 on Wednesday, up from a previous close of A$1.94. They traded between A$1.92 and A$2.04, leaving the miner near the top of its 52-week range and about A$6 billion in market value. 1

The move comes as investors chase lithium miners on signs the market’s long slump is easing. “The data centre building boom in China and globally has also driven growing power storage demand for lithium,” said Jinyi Su, a Wuxi-based analyst at consultancy Fubao. UBS data show lithium demand for energy storage jumped 71% in 2025 and is forecast to rise 55% in 2026, while some market forecasts point to a swing to deficits this year after a 2025 surplus. 2

Market Index said brokers have also sharpened their focus on grid-scale batteries, arguing stronger energy storage demand can tighten the market before new supply responds. The publication flagged Liontown’s Kathleen Valley operation in Western Australia — alongside larger peers such as Pilbara Minerals, Mineral Resources and IGO — as among the ASX names most exposed to a firmer pricing backdrop for spodumene concentrate, the lithium-rich ore used to make battery chemicals. 3

For Liontown, traders will look for evidence that stronger lithium pricing is filtering into realised sales prices and cash generation as it continues to ramp operations.

With the market closed, chart watchers will test whether the stock can hold above A$2.00 after Wednesday’s push into new highs, rather than slipping back into the mid-A$1.90s where buyers last stepped in.

But the rally leans on a still-fragile commodity turn. Lithium prices can retreat quickly if producers restart idled capacity faster than demand grows, or if buyers run down inventories instead of returning to spot purchases.

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Mineral Resources shares slip from fresh 52-week high as lithium rally keeps investors on edge
Previous Story

Mineral Resources shares slip from fresh 52-week high as lithium rally keeps investors on edge

4DMedical shares jump on UC San Diego Health CT:VQ rollout as market eyes next catalyst
Next Story

4DMedical shares jump on UC San Diego Health CT:VQ rollout as market eyes next catalyst

Go toTop